Aura Biosciences, Inc. (AURA) vs Monopar Therapeutics Inc. (MNPR)

Aura Biosciences, Inc. and Monopar Therapeutics Inc. are both Biotechnology companies. Aura Biosciences, Inc. and Monopar Therapeutics Inc. are of similar size ($637.8M and $602.8M). Across the 8 metrics below, Monopar Therapeutics Inc. leads on 6 and Aura Biosciences, Inc. on 2.

Valuation

Metric AURA MNPR Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.81 5.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (29.17%) (2.55%) (28.84%)
Free cash flow yield (18.16%) (1.67%) (23.03%)

Profitability

Metric AURA MNPR Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (53.49%) (19.50%) (57.72%)
Return on assets (47.42%) (18.90%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AURA MNPR Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (0.57%) 54.99% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA MNPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.82 33.56 4.73
Net debt to EBITDA 1.29 8.06 0.96

Dividend

Metric AURA MNPR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AURA MNPR Biotechnology median
Market cap 637.78m 602.75m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack